Current Understanding of Risk Factors for Ovarian Cancer

被引:57
作者
Sueblinvong, Thanasak [1 ]
Carney, Michael E. [1 ]
机构
[1] John A Burns Sch Med, Dept Obstet & Gynecol, Honolulu, HI 96826 USA
关键词
HORMONE REPLACEMENT THERAPY; ORAL-CONTRACEPTIVE USE; PELVIC-INFLAMMATORY-DISEASE; PERINEAL TALC EXPOSURE; SWEDISH CASE-CONTROL; STATES CASE-CONTROL; LIFE-STYLE FACTORS; VITAMIN-D; OVULATION INDUCTION; ALCOHOL-CONSUMPTION;
D O I
10.1007/s11864-009-0108-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer is the deadliest gynecologic cancer. Unlike many cancers such as breast, cervical and colon cancers, there is no easily clinically identifiable pre-malignant phase of this malignancy making early identification difficult. Similarly, unlike lung, head and neck, and skin cancers, there is not easily identifiable risk factor making prevention short of oophorectomy difficult. Even so, theories as to the causative factors of ovarian cancer continue to evolve making our understanding of the genesis of ovarian cancer more clear. Genetics, parity, environment, hormonal factors, and inflammation all play an important and pivotal role in the development of ovarian cancer. The most current understanding of these elements and their respective contribution to the development of this cancer are presented in this chapter.
引用
收藏
页码:67 / 81
页数:15
相关论文
共 125 条
[1]   PARITY, AGE AT FIRST CHILDBIRTH, AND RISK OF OVARIAN-CANCER [J].
ADAMI, HO ;
HSIEH, CC ;
LAMBE, M ;
TRICHOPOULOS, D ;
LEON, D ;
PERSSON, I ;
EKBOM, A ;
JANSON, PO .
LANCET, 1994, 344 (8932) :1250-1254
[2]   Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial [J].
Anderson, GL ;
Judd, HL ;
Kaunitz, AM ;
Barad, DH ;
Beresford, SAA ;
Pettinger, M ;
Liu, J ;
McNeeley, SG ;
Lopez, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1739-1748
[3]  
[Anonymous], 1987, NEW ENGL J MED, V316, P650
[4]  
Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173
[5]   Polycystic ovary syndrome and cancer [J].
Balen, A .
HUMAN REPRODUCTION UPDATE, 2001, 7 (06) :522-525
[6]   UTERINE AND OVARIAN-CARCINOMA IN A PATIENT RECEIVING GONADOTROPIN THERAPY - CASE-REPORT [J].
BAMFORD, PN ;
STEELE, SJ .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1982, 89 (11) :962-964
[7]   The epidemiology of ovarian cancer: A population-based study in Olmsted County, Minnesota, 1935-1991 [J].
Beard, CM ;
Hartmann, LC ;
Atkinson, EJ ;
O'Brien, PC ;
Malkasian, GD ;
Keeney, GL ;
Melton, LJ .
ANNALS OF EPIDEMIOLOGY, 2000, 10 (01) :14-23
[8]   Nutrient intake and ovarian cancer: an Italian case-control study [J].
Bidoli, E ;
La Vecchia, C ;
Montella, M ;
Dal Maso, L ;
Conti, E ;
Negri, E ;
Scarabelli, C ;
Carbone, A ;
Decarli, A ;
Franceschi, S .
CANCER CAUSES & CONTROL, 2002, 13 (03) :255-261
[9]   RISK-FACTORS FOR OVARIAN-CANCER - A CASE CONTROL STUDY [J].
BOOTH, M ;
BERAL, V ;
SMITH, P .
BRITISH JOURNAL OF CANCER, 1989, 60 (04) :592-598
[10]   Diet and ovarian cancer risk: A case-control study in Italy [J].
Bosetti, C ;
Negri, E ;
Franceschi, S ;
Pelucchi, C ;
Talamini, R ;
Montella, M ;
Conti, E ;
La Vecchia, C .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (06) :911-915